Latest news
AVITA Medical Reports Q2 2026 Revenue of US$21.7M, Updates Full-Year Guidance to US$86M–US$89M - KalkineKalkine · Mon, 10 Aug 2026 02:34:07 GMTDoes Raised 2026 Revenue Guidance Change The Bull Case For Kiniksa Pharmaceuticals International (KNSA)? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:32 GMTIs Insmed (INSM) Cheap After Q2 Revenue Growth And Raised Guidance? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:35:43 GMTIs Sempra (SRE) Undervalued Following Q2 Earnings And Updated 2026 Guidance? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 10:09:08 GMTHow Investors May Respond To Alignment Healthcare (ALHC) Raising 2026 Revenue Guidance After Strong Q2 Results - simplywall.stsimplywall.st · Fri, 07 Aug 2026 22:27:54 GMTUpdate: Take-Two Interactive Software Fiscal Q1 Loss Widens, Revenue Increases; Fiscal 2027 Guidance Reiterated - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 12:34:12 GMTWill Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 07:19:16 GMTAvePoint lifts annual recurring revenue guidance after Q2 - CFOtech AsiaCFOtech Asia · Fri, 07 Aug 2026 06:44:00 GMT